Catalyst Wire Dossier Catalyst Wire Dossier

NN5401 Formulation B

NN5401 formulation B · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NN5401 Formulation B, covering 2015-11-17 to 2015-11-17. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Two NN5401 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes [Phase 2]

See pricing